How Primary Care Practices Are Valued
Primary care valuation in 2026 is shaped by one structural shift: value-based care (VBC). Practices that have built capability around risk contracts, ACO participation, and full-risk Medicare Advantage relationships trade at multiples 2-4x higher than equivalent fee-for-service practices. The arbitrage is enormous, and it's why every PE platform in the space (One Medical pre-Amazon, Oak Street pre-CVS, Iora, ChenMed, Aledade, Privia) was built on this thesis.
Solo / Small Group Primary Care: 40-70% of Collections
A solo or 2-3 physician primary care practice doing $1.5-3M in collections with $250-500K SDE typically trades at 40-70% of annual collections, or 1.5-2.5x SDE. The spread reflects:
- Patient panel size: 1,500+ active patients per physician is healthy; 2,500+ is premium. Below 1,000 suggests under-utilization or market saturation.
- Payer mix: commercial-heavy practices command premium; high Medicaid mix gets discounted (lower reimbursement, tighter margins).
- Physician dependency: practices with a strong advanced-practice provider (NP/PA) team trade higher because revenue survives a physician transition.
- Ancillary revenue: in-house labs, point-of-care imaging, in-office dispensing add 15-25% to total revenue at 60%+ margin — that revenue trades at premium multiples.
Mid-Size Group: 50-95% of Revenue, 4-9x EBITDA
Once a practice has 4-15 physicians, ancillaries, and professional management, valuation shifts to EBITDA. The range widens: 4-9x EBITDA for fee-for-service mid-size groups, with the high end requiring strong commercial payer mix and documented cost discipline.
Mid-size groups participating in value-based care arrangements (Medicare Shared Savings, ACO REACH, full-risk MA contracts) trade higher because the recurring shared-savings revenue and capitated payments are stickier and underwritable. A mid-size group with 30%+ of revenue from VBC arrangements often trades at 7-11x EBITDA.
PE-Backed VBC Platforms: 100-200%+ of Revenue
At platform scale, the math diverges entirely from fee-for-service comps. Recent transactions:
- Amazon's One Medical acquisition: $3.9B at ~5x revenue
- CVS's Oak Street Health acquisition: $10.6B at ~5.5x revenue
- Walgreens' VillageMD investment + Summit Health acquisition
- Privia Health (PRVA) trades public at 1.5-2.5x revenue
Private VBC platforms in the $50-500M revenue range often trade 2-5x revenue depending on growth, payer mix, and the percentage of revenue from full-risk arrangements. Aledade, ApolloMed, ChenMed anchor the comp set.
Why Hospital Systems Buy Primary Care (and What They Pay)
Hospital systems acquire primary care practices for downstream referral capture — the practice becomes a feeder for the hospital's specialty practices and inpatient base. Hospital-system buyers typically pay 50-80% of revenue for solo/small practices, but offer cleaner exits (full cash, no earnout) and employment agreements with relatively favorable physician compensation structures.
For owner-physicians at retirement age looking for a clean exit, hospital systems are often the right buyer even at slightly lower headline multiples than PE platforms. The trade-off: lose autonomy, gain certainty.
What Drives Premium Multiples
Value-based care participation: Medicare Shared Savings achieved-savings track record, ACO REACH benchmarks, full-risk MA capitation rates. Practices with documented per-member-per-month economics command premiums.
Ancillary revenue depth: labs, imaging, infusion, in-office dispensing. Each adds margin and stickiness.
Physician productivity: RVUs per physician, patients per day, panel size. Buyers benchmark against MGMA medians.
Provider model balance: practices with NPs/PAs handling routine visits while physicians focus on complex cases command premium because the model scales without requiring more physicians.
What Reduces Valuations
Physician retirement / departure: if the owner-physician is the largest revenue contributor and exiting at close, expect 30-40% discount or significant earnout structure.
Reimbursement pressure: practices in markets with below-market commercial reimbursement contracts get discounted because buyers project further compression.
Administrative burden: practices behind on EHR adoption, MIPS reporting, or PCMH recognition get discounted because buyers must invest to bring them up to standard.
Nurse practitioner competition: in markets where NP independent practice is widespread, traditional physician-owned primary care faces volume competition that compresses multiples.
Who Buys Primary Care Right Now
PE-backed VBC platforms — Privia, Agilon, Aledade (network model), Iora-style — buy mid-size groups for VBC capability. Highest multiples, most complex deal structures.
Hospital systems — most major IDNs (HCA, Tenet, Universal Health, regional systems) actively acquire primary care for referral funnels. Mid-range multiples, cleanest exits.
Retail healthcare — CVS (Oak Street), Walgreens (VillageMD/Summit Health), Walmart Health (in select markets), Amazon (One Medical) — selectively acquire at platform scale.
Physician-led private platforms — Privia, Crozer, various regional consolidators — buy at fair multiples and offer physician partnership/equity structures.